Pasithea Therapeutics Corp. (KTTA): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$34.3K
Year ended 2023-12-31
$107.1K2021-12-31: $21.5K2022-12-31: $107.1K2023-12-31: $34.3K$34.3K
2021-12-31 Capital Expenditures (USD) 2023-12-31
Period endedCapital ExpendituresChange YoYSource filing
2023-12-31$34.3K-68.0%2025-03-24, From 2023-01-01
2022-12-31$107.1K+398.1%2024-03-29, From 2022-01-01
2021-12-31$21.5Kn/a2023-03-30, From 2021-01-01